Legend Biotech Corp (ADR) - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
LEGN Nasdaq 8731 https://investors.legendbiotech.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Legend Biotech Corp (ADR)

CARVYKTI® (ciltacabtagene autoleucel) Approved by the European Commission for Second-line Treatment of Patients with Relapsed and Refractory Multiple Myeloma - Apr 22nd, 2024 5:05 pm
Legend Biotech to Host Investor Conference Call on First Quarter 2024 Results - Apr 11th, 2024 12:00 pm
FDA Expands J&J's (JNJ) Carvykti Label in Multiple Myeloma - Apr 8th, 2024 1:40 pm
Why Legend Biotech (LEGN) Stock Might be a Great Pick - Apr 8th, 2024 12:48 pm
Legend Biotech’s CARVYKTI® (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myeloma - Apr 6th, 2024 3:30 am
Should You Continue to Hold Legend Biotech Corporation (LEGN)? - Apr 3rd, 2024 9:39 am
Management’s Conservative Guidance Led Legend Biotech Corporation (LEGN) to Decline in Q4 - Mar 29th, 2024 9:09 am
Legend Biotech Announces Publication of Inaugural Environmental, Social and Governance (ESG) Report - Mar 19th, 2024 12:30 pm
30 Biggest Biotechnology Companies in the World - Mar 17th, 2024 12:50 pm
CARVYKTI® (ciltacabtagene autoleucel) Receives Recommendation from the U.S. FDA Oncologic Drugs Advisory Committee for Earlier Treatment of Patients with Relapsed/Refractory Multiple Myeloma - Mar 15th, 2024 7:15 pm
Legend Biotech Corporation (NASDAQ:LEGN) Q4 2023 Earnings Call Transcript - Mar 12th, 2024 12:20 pm
The Zacks Analyst Blog Highlights Legend Biotech, Exact Sciences, Exelixis, Ascendis Pharma and MorphoSys - Mar 11th, 2024 2:36 pm
Legend Biotech Reports Fourth Quarter and Full Year 2023 Results and Recent Highlights - Mar 11th, 2024 11:00 am
5 Biotechnology Stocks to Buy for a Stable Portfolio in 2024 - Mar 8th, 2024 12:31 pm
An Intrinsic Calculation For Legend Biotech Corporation (NASDAQ:LEGN) Suggests It's 47% Undervalued - Feb 24th, 2024 12:00 pm
Legend Biotech Announces Positive CHMP Opinion for CARVYKTI® (ciltacabtagene autoleucel) for the Treatment of Patients with Relapsed and Lenalidomide Refractory Multiple Myeloma in Earlier Lines of Therapy - Feb 23rd, 2024 12:15 pm
Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2023 Results - Feb 13th, 2024 1:00 pm
Matthews Emerging Markets Small Companies Fund Bolsters Position in CarTrade Tech Ltd - Feb 7th, 2024 7:41 am
UPDATE 6-US FDA seeks 'boxed warning' for CAR-T cancer therapies - Jan 23rd, 2024 1:34 am
US FDA requires 'boxed warning' for CAR-T cancer therapies - Jan 23rd, 2024 1:11 am